drugset / Trial / NCT03341741

Combined Dry Powder Tobramycin and Nebulized Colistin Inhalation in CF Patients

NCT03341741

Phase 3 Completed 26 enrolled University Hospital Tuebingen
RandomizedParallel-groupOpen-labelTreatment

Summary

To assess whether the inhalative combination of Tobramycin/Colistin is more effective in reducing Pseudomonas colony forming units (CFUs) and improvement of lung function than Colistin in mono-therapy.

Timeline

Start
2014-03-11
Primary completion
2015-12-19
Completion
2016-11-25

Drugs

EvaluationDrugModalityDoseRoute
Subject Colistin Other / unclassified 1 unknown Inhaled
Subject Tobramycin Small molecule 112 mg Inhaled

Indications